1Malsonpiewe PC,Suri C,Jones PF,et al.Angiopoietin-2,a natural antagonist for tie-2that disrupts in vivo angiogenesis[J].Science,1997,277(5322):55-60.
2Suri C,Jones PF,Patan S,et al.Requisite role of angiopoietin-1:a ligand for the tie-2 receptor during embryonic angiogenesis[J].Cell,1996,87(7):1171-1180.
3Valenzuela DM,Griffiths J,Rojas J,et al.Angiopoietin3and4:diverging gene counterparts in mouse and man [J].Proc Natl Acad Sci USA,1999,96(5):1904-1909.
4Stratmann A,Risau W,Plate KH,et al.Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis[J].Am J Patho,1998,153(5):1459-1466.
5Zagzag D,Amirnovin R,GrewMA.Vascular apoptosis and involution in gliomas precede neovascularization:A novel concept for glioma growth and angiogenesis[J].Lab Invest,2000,80(6):837-849.
6Bunone G,Vigneri P,Mariani L,et al.Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical patho,ogical feature[J].Am J Pathol,1999,155(6):1967-1976.
7Davis S,Aldrich Th,Jones PF,et al.Isolation of angiopoietin-1,a ligand for the tie2 receptor by secretion-trap expression cloning[J].Cell,1996,87(7):1161-1169.
9Folkman J.Angiogenensis in cancer,vascular rhenmatoid and other disease [J].Nat med,1995,1:27-31.
10Fujikawa D,De-Aos-Scherpenseen-I,Jain-SK,et al.Role of PI3-kinase in angiopoietin-1 mediated migration and attchment dependent survival of endothelial cells[J].Exp Cell Res,1999,253(2):663-672.
二级参考文献65
11.Brown TJ, Friedman J, Levy ML. The diagnosis and treatment of common birthmarks. Clin Plast Surg, 1998, 25(4): 509.
22.Cheung DS, Warman ML, Mulliken JB. Hemangioma in twins. Ann Plast Surg, 1997, 38(3): 269.
33.Jackson LT, Sosa J. Excision of nasal tip hemangioma via open rhinoplasty-a skin sparing technique. Eur J Plast Surg, 1998, 21: 265.
44.Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol, 1997, 14(3): 173.
55.Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol, 1997, 19(3): 237.
66.Chang J, Most D, Bresnick B, et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg, 1999, 103(1): 1.
77.Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr, 1996, 128(3): 329.
88.Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg, 1997, 99(5): 1301.
99.Jackson IT, Carreno R, Potparic Z, et al. Hemangiomas, vascular malformations, and lyphovenous malformations: classification and methods of treatment. Plast Reconstr Surg, 1993, 91(7): 1216.
1010.Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg, 1982, 69(3): 412.
